C2 domains are autonomously folded protein modules that generally act as Ca 2؉ -and phospholipid-binding domains and/or as protein-protein interaction domains. We now report the primary structures and biochemical properties of a family of evolutionarily conserved mammalian proteins, referred to as E-Syts, for extended synaptotagmin-like proteins. E-Syts contain an N-terminal transmembrane region, a central juxtamembranous domain that is conserved from yeast to human, and five (E-Syt1) or three (E-Syt2 and E-Syt3) C-terminal C 2 domains. Only the first E-Syt C2 domain, the C 2A domain, includes the complete sequence motif that is required for Ca 2؉ binding in C2 domains. Recombinant protein fragments of E-Syt2 that include the first C 2 domain are capable of Ca 2؉ -dependent phospholipid binding at micromolar concentrations of free Ca 2؉ , suggesting that E-Syts bind Ca 2؉ through their first C 2 domain in a phospholipid complex. E-Syts are ubiquitously expressed, but enriched in brain. Expression of myc-tagged E-Syt proteins in transfected cells demonstrated localization to intracellular membranes for E-Syt1 and to plasma membranes for E-Syt2 and E-Syt3. Structure/function studies showed that the plasmamembrane localization of E-Syt2 and E-Syt3 was directed by their C-terminal C 2C domains. This result reveals an unexpected mechanism by which the C 2C domains of E-Syt2 and E-Syt3 functions as a targeting motif that localizes these proteins into the plasma membrane independent of their transmembrane region. Viewed together, our findings suggest that E-Syts function as Ca 2؉ -regulated intrinsic membrane proteins with multiple C 2 domains, expanding the repertoire of such proteins to a fourth class beyond synaptotagmins, ferlins, and MCTPs (multiple C 2 domain and transmembrane region proteins).
calcium ͉ exocytosis ͉ membrane traffic ͉ protein targeting C 2 domains were identified as a conserved sequence motif in protein kinase C isoforms (1) and shown to represent autonomously folded Ca 2ϩ -binding domains in synaptotagmin-1 (2, 3). C 2 domains are now recognized as the second most common Ca 2ϩ -binding module in the proteome after the smaller, more frequent EF-hand module (4) . All C 2 domains are composed of a stable eight-stranded ␤-sandwich that contains flexible loops at the top and bottom, with ''top'' and ''bottom'' defined by reference to the synaptotamin-1 C 2 A domain, the first C 2 domain whose atomic structure and Ca 2ϩ -binding mode were determined (5, 6) . C 2 domains come in two topological variations that are circular permutations of each other (reviewed in ref. 6 ). In type I C 2 domains, e.g., those of synaptotagmin-1, the ␤-strands are arranged in a linear manner and the C and N termini emerge at the top of the domain (5) . In contrast, in type II C 2 domains as first found in the phospholipase C␦ C 2 domain (7), the N terminus of the C 2 domain is formed by ␤-strand 2 and the C terminus by ␤-strand 1, and the N and C termini emerge at the bottom of the C 2 domain. In all C 2 domains that bind Ca 2ϩ , Ca 2ϩ binds exclusively to the top loops, coordinated by five conserved aspartate or asparagine residues (8) . Although the Ca 2ϩ -binding modes of all C 2 domains are the same, their precise Ca 2ϩ -binding properties differ. Some C 2 domains, such as those of synaptotagmin-1, exhibit a low intrinsic Ca 2ϩ affinity that is boosted several orders of magnitude by the presence of phospholipids (2, 8) . In contrast, other C 2 domains, such as those of rabphilin, display a high intrinsic Ca 2ϩ affinity even in the absence of phospholipids (9) . Moreover, not all C 2 domains bind Ca 2ϩ . A subset of C 2 domains lacks the residues involved in Ca 2ϩ binding, making Ca 2ϩ binding impossible (e.g., see refs. 10 and 11). More surprisingly, at least in the C 2 B domain of synaptotagmins 4 and 11, the canonical Ca 2ϩ -binding residues are present, but the domains nevertheless do not bind Ca 2ϩ because a subtle change in the orientation of the ␤-strands makes it impossible for the top loops to actually coordinate Ca 2ϩ (12) . Most but not all Ca 2ϩ -dependent, and some Ca 2ϩ -independent, C 2 domains bind to phospholipids, as initially found for the synaptotagmin-1 C 2 A domain (2, 3) and the Pten C 2 domain (10), respectively. In addition, several Ca 2ϩ -independent C 2 domains constitute protein-interaction domains, as revealed in the crystal structure of the Munc13-1 C 2 A domain in a complex with the RIM zinc finger domain (13) . Moreover, at least in synaptotagmin-1, Ca 2ϩ -binding to the C 2 domains triggers their interaction with both phospholipids and SNARE complexes, suggesting a multifaceted functional activity at the phospholipid/protein interface (14, 15) and demonstrating that the same C 2 domain can simultaneously bind to protein and phospholipids.
C 2 domains are primarily found in proteins that function in membrane traffic and/or signal transduction, with synaptotagmins and protein kinase C as the prime examples. In membrane trafficking proteins, C 2 domains are generally present in multiple copies, whereas signal transduction proteins usually have only a single C 2 domain. In the latter, the C 2 domains usually function to localize the respective protein to the membrane, as shown for example for protein kinase C (16) or Pten (10) . In contrast, in C 2 -domain proteins that function in membrane traffic, the C 2 domains generally act as effector domains, with the proteins being attached to membranes either by a transmembrane region (TMR; e.g., see synaptotagmins) or by binding to a membrane protein [e.g., see rabphilin that binds to Rab3 (17) ]. Few C 2 -domain proteins are conserved in yeast, for example the phosphatidylserine decarboxylase Psd2p (reviewed in ref. 18) , protein kinase C (19) , and the ubiquitin ligase Rsp5p (20) .
Three families of putative trafficking proteins containing multiple C 2 domains and a single TMR have been described: synaptotagmins, ferlins, and MCTPs (21) (22) (23) . In addition, the Author contributions: T.C.S. designed research; S.-W.M. and W.-P.C. performed research; S.-W.M., W.-P.C., and T.C.S. analyzed data; and T.C.S. wrote the paper.
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sequence of a fourth type of protein with multiple C 2 domains and a single TMR was reported from rat adipocytes (24) . Interestingly, this adipocyte protein is evolutionarily related to a family of membrane proteins in yeast containing three C 2 domains that were called tricalbins (25) . Tricalbins may thus be noteworthy because they may represent the only proteins resembling synaptotagmins that are conserved in yeast, although the properties and expression of these proteins and their mammalian counterparts have not been examined.
In this study, we define a family of homologous proteins that we refer to as E-syts, for extended synaptotagmins, because of their similarity to synaptotagmins. E-Syts differ from yeast tricalbins, to which they are related, in that they are Ca 2ϩ -binding proteins. E-Syt1 contains five domains, and E-Syt2 and E-Syt3 contain three C 2 domains. E-Syt1 is localized to intracellular membranes, whereas E-Syt2 and E-Syt3 are localized to the plasma membrane. Interestingly, E-Syt2 and E-Syt3 are targeted to the plasma membrane by a mechanism that does not depend on their TMR, but is instead determined by their Ca 2ϩ -independent third C 2 C domain. Thus, E-Syts represent a family of Ca 2ϩ -binding membrane proteins that form a heterogeneous group of proteins, two of which are targeted to the plasma membrane by a unique mechanism.
Results

Structure and Expression of E-Syts.
We identified E-Syts by databank searches for C 2 domain proteins that contain a TMR (26) . Analyses of vertebrate sequences uncovered three evolutionarily conserved and closely related E-Syt proteins that are distantly homologous to yeast tricalbins (25) . One of these proteins, named here E-Syt1, was originally described by Morris et al. (24) as an anonymous membrane protein isolated from intracellular vesicles. We assembled full-length sequences for E-Syt1, E-Syt2, and E-Syt3 from EST clones and verified their primary structures by sequencing multiple independent clones and comparing the resulting sequences with database entries. The domain structures of E-Syts emerging from these analyses are shown in Fig. 1 , and an alignment of the human E-Syt sequences and of their worm and insect homologs is depicted in [supporting information (SI) Fig. 5 ].
E-Syts consist of a short, nonconserved N-terminal sequence, a single N-terminal TMR, a conserved domain that differs from other identified domains in the databanks (here referred to as ''X''), and either five C 2 domains (E-Syt1) or three C 2 domains (E-Syt2 and E-Syt 3). The TMR, X domain, and C 2 A domain closely follow each other without a discernable linker sequence separating them. In contrast, the C 2 A and C 2 B domains in all E-Syts are connected by a short variable linker (Ϸ20 residues), and the C 2 B and C 2 C domains are connected by a long variable E-Syt1 Fig. 1 . Domain structures of E-Syts. T, TMR; X, X domain unique to E-Syts; C2A to C 2E, C2 domains (note that the C2C and C2D domains of E-Syt1 are highly homologous to the C 2A and C2B domains of all E-Syts). linker (Ͼ100 residues). Apart from the X domain, the C 2 domains, and the linker sequences, E-Syts have no recognizable domains, suggesting that their functions are mediated by the X and C 2 domains. In E-Syt1, the third and fourth C 2 domains (the C 2 C and C 2 D domains that are absent from E-Syt2 and E-Syt3) are highly homologous to the first and second C 2 domains (the C 2 A and C 2 B domains), respectively (SI Fig. 5 ). This suggests that evolutionarily, the C 2 C and C 2 D domains were duplicated in E-Syt 1 ( Fig. 1 and SI Fig. 5) .
All E-Syt C 2 domains are composed of a type 2 topology as defined originally for the phospholipase C␦ C 2 domain (7). In mammalian, worm, and insect E-Syts, only the C 2 A domain contains the canonical Ca 2ϩ -binding residues in the top loops between ␤-strands 2/3, 4/5, and 6/7. The other C 2 domains lack several of the critical Ca 2ϩ -binding asparate/aparagine residues in these loops, suggesting that they are unlikely to bind Ca 2ϩ . The sequences of the C 2 domains do not otherwise contain noticeable features except for the presence of a relatively long sequence in the top loop between ␤-strands 2/3 in the C 2 B domains of the vertebrate E-Syts, suggesting that this loop may have a more extensive structure. Interestingly, this long loop sequence is alternatively spliced, at least in E-Syt1 and E-Syt2 (SI Fig. 5) .
To determine the tissue distribution of E-Syt expression, we performed RT-PCR analyses on various human tissues using E-Syt1-, E-Syt2-, and E-Syt3-specific primers and a normal human tissue cDNA panel (PrimGen, Bothell, WA) (see SI Experimental Procedures). We observed ubiquitous expression of all E-Syts, with an enrichment of E-Syt2 and E-Syt3 in cerebellum SI Fig. 6 .
Phospholipid Binding by E-Syt2. Because sequence analyses suggested that the C 2 A domain of E-Syts bind Ca 2ϩ , we investigated their potential Ca 2ϩ -binding properties using a series of recombinant proteins containing various fragments from E-Syt2 expressed as GST fusion proteins ( Fig. 2A) . We tested the binding of these protein fragments to liposomes composed of 25% phosphatidylserine (PS)/75% phosphatidylcholine (PC) in the absence or presence of divalent cations, using a sensitive centrifugation assay. We detected no phospholipid binding in the absence of divalent cations or in the presence of Mg 2ϩ with any E-Syt2 fragments. In contrast, fusion proteins of the C 2 A domain, with either the X domain or the C 2 B domain or both, bound to liposomes in a Ca 2ϩ -specific manner. Although the only common denominator of these different E-Syt2 fragments was the presence of the C 2 A domain (Fig. 2 A) , the isolated C 2 A domain by itself only weakly bound to phospholipids in a Ca 2ϩ -dependent manner (Fig. 2B) , possibly because the fragment used did not exactly include the precise domain boundaries.
We next examined the apparent Ca 2ϩ affinity and phospholipid specificity of Ca 2ϩ -dependent phospholipid binding by the E-Syt2 X C 2 AB domain fragment (Fig. 2C) . Binding was observed at micromolar concentrations of free Ca 2ϩ , similar to that observed for the synaptotagmin-1 C 2 domains. Different from the synaptotagmin-1 C 2 domains, however, E-Syt2 Ca 2ϩ -dependent phospholipid binding was not specific for negatively charged phospholipid but was also detectable with liposomes composed of neutral phospholipids (PE and PC; Fig. 2C ), although negatively charged phospholipids exhibited a higher apparent Ca 2ϩ affinity.
Subcellular Localization of E-Syts.
To determine the subcellular localization of E-Syts, we raised antibodies to various E-Syts by using recombinant protein fragments but were unable to generate antibodies of sufficiently high affinity to detect endogenous E-Syt proteins (data not shown). Thus, to circumvent this problem, we constructed vectors that express E-Syts with an N-terminal myc-epitope tag, either as full-length proteins or as N-terminally truncated proteins lacking the TMR. Expression of all of these proteins from the respective vectors was confirmed by immunoblotting in transfected HEK293 and COS cells (data not shown).
To immunolocalize E-Syts, we transfected HEK293 cells with the expression vectors and stained the cells with anti-myc epitope antibodies either without or with permeabilization (Fig. 3) . This experiment was designed to test whether E-Syts are plasma membrane proteins, because plasma membrane localization would expose their N-terminal myc-tagged sequences on the cell surface and thus make them accessible to immunolabeling without permeabilization. As a positive control, we used Nterminally myc-tagged synaptotagmin-7 that is quantitatively deposited into the plasma membrane (27) ; as a negative control, we used N-terminally myc-tagged filamin A, an intracellular protein. Moreover, the N-terminally truncated E-Syts served as a further control because they do not contain noncytoplasmic sequences and thus should not be exposed on the cell surface. All transfected cells were probed with myc antibodies and with fluorescent phalloidin (to label the actin cytoskeleton).
We made three principal observations: (i) E-Syt1 was not detected in unpermeabilized cells but was observed in permeabilized cells in an unidentified intracellular compartment that did not resemble the Golgi apparatus, endoplasmic reticulum, lysosomes, or mitochondria (Fig. 3) ; (ii) E-Syt2 and E-Syt3 were fully stained on the cell surface in unpermeabilized transfected cells and appeared to be completely inserted into the plasma membrane, because permeabilization did not uncover additional intracellular staining for these E-Syts (Fig. 3) ; and (iii) the localization of E-Syts did not change upon removal of the TMR. As expected, E-Syt2 and E-Syt3 without a TMR could no longer be detected on the cell surface in unpermeabilized cells; nevertheless, they were still found to be quantitatively associated with the plasma membrane (Fig. 3) . Thus the localization of E-Syt2 and E-Syt3 into close proximity to the plasma membrane does not depend on the TMR.
Plasma Membrane Targeting of E-Syt2 and E-Syt3 Is Mediated by Its
C-Terminal C2 Domain. To investigate which sequences target E-Syt2 and E-Syt3 to the plasma membrane even in the absence of the TMR, we produced E-Syt2 deletion constructs that contained an N-terminal myc epitope and were analyzed by transfection into HEK293 cells (Fig. 4A) . We found that deletion of the C 2 C domain abolished the plasma membrane localization of E-Syt2. In contrast, partial or complete deletion of the TMR, X domain, and/or the C 2 A domain had no effect on the plasma membrane localization of E-Syt2 (Fig. 4B) . We next tested whether the C 2 C domain of E-Syt2 is sufficient for plasma membrane localization and whether this property is shared with the C-terminal C 2 domains of other E-Syts by examining the localization of isolated C-terminal C 2 domains in transfected HEK293 cells (Fig. 4 B and C) . Both the E-Syt2 and the E-Syt3 C 2 C domains were localized to the plasma membrane, whereas the E-Syt1 C 2 E domain was not, thus mirroring the localizations of the full-length proteins. Therefore, although the C-terminal C 2 domains of E-Syt1, E-Syt2, and E-Syt3 share a high degree of sequence homology, only the latter two include targeting information that deposits them on the intracellular surface of the plasma membrane.
To investigate how it is possible for the E-Syt2 and E-Syt3 C 2 C domains to be localized to the plasma membrane, we evaluated their biochemical properties. The E-Syt2 fragment containing the C 2 B and C 2 C domains is strongly expressed in HEK293 cell and quantitatively localized to the plasma membrane (Fig. 4B) . Subcellular fractionations revealed that the C 2 B/C 2 C domain fragment was insoluble even after extraction of the cells with 1% Triton X-100 (SI Fig. 7 ; see SI Experimental Procedures). Disrupting the actin cytoskeleton with latrunculin or the microtubule cytoskeleton with nocodazole, however, had no effect on the solubility of the E-Syt2 C 2 B/C 2 C domain fragment or its plasma membrane localization, despite the fact that, at least in the case of latrunculin-A, the actin cytoskeleton was disrupted (SI Fig. 7) . Thus, the E-Syt2 C 2 B/C 2 C domain fragment is not simply anchored to the plasma membrane by the cortical cytoskeleton.
Discussion
E-Syts as Membrane-Tethered Ca 2؉ -Binding Proteins. We here describe a family of membrane proteins with multiple C 2 domains, referred to as E-Syts because, like synaptotagmins, these proteins contain an N-terminal TMR and C-terminal cytoplasmic C 2 domains. With the E-Syts, four families of evolutionarily conserved membrane proteins containing C 2 domains that bind Ca 2ϩ have now been defined: synaptotagmins, ferlins, MCTPs, and E-Syts (26, 28, 29) . All of these proteins contain a single TMR and multiple C 2 domains, from two C 2 domains for synaptotagmins to at least six C 2 domains for ferlins. E-Syts share other properties with synaptotagmins, ferlins, and MCTPs: two of the three E-Syt isoforms are localized to the plasma membrane, as are some of the synaptotagmin and ferlin isoforms, and E-Syts are ubiquitously expressed, although enriched in brain, as again shown for some synaptotagmin and ferlin isoforms. However, two of these protein families, synaptotagmins and E-Syts, contain an N-terminal TMR, whereas the other two, ferlins and MCTPs, contain a C-terminal TMR. Moreover, as described here, E-Syts differ from the other proteins, with multiple C 2 domains and a single TMR in three key properties:
The cytoplasmic sequences of E-Syts include an additional, highly conserved domain that is not found in other proteins with multiple C 2 domains, here referred to as the X domain for want of a better name (Fig. 1) .
E-Syts are the only proteins with a single TMR and multiple C 2 domains that are conserved in yeast, where they are closely related to tricalbins. However, in all E-Syts, the C 2 A domain contains a signature Ca 2ϩ -binding motif that is characteristic of Ca 2ϩ -binding C 2 domains and that mediates Ca 2ϩ binding (Fig. 2) , whereas in tricalbins, none of the C 2 domains contains a Ca 2ϩ -binding motif, making it highly unlikely that they bind Ca 2ϩ .
Although the C 2 A domain of E-Syt2 appears to mediate Ca 2ϩ -dependent phospholipid binding, its Ca 2ϩ -dependent phospholipid binding properties are unusual compared with those of other proteins containing a single TMR and multiple C 2 domains. The E-Syt2 phospholipid binding specificity is such that it does not require negatively charged phospholipids but also works with neutral phospholipids (Fig. 2C) . Moreover, the isolated C 2 A domain does not appear to work efficiently but exhibits a significant amount of Ca 2ϩ -dependent phospholipid binding only when expressed in conjunction with either the X domain or the C 2 B domain (Fig. 2 A) , a property that we do not currently understand.
E-Syts have no recognizable domains besides their TMR, X domain, and C 2 domains, suggesting that their function is mediated by the combination of these three sequence elements. The overall characteristics of E-Syts suggest that E-Syts are Ca 2ϩ -regulatory proteins that function in conjunction with membranes. At present, the physiological roles of E-Syts are unclear, but both synaptotagmins and ferlins are involved in the Ca 2ϩ -dependent regulation of exocytosis (reviewed in refs. 29 and 30) , suggesting that MCTPs and E-Syts may also have a role in membrane traffic. It seems likely that E-Syts have an important role, because they are evolutionarily conserved, and because yeast tricalbins appear to be essential for survival (25) . Moreover, the distinct localizations of E-Syt1 vs. E-Syt2 and E-Syt3 point to divergent functions, consistent with their different domain structures. Detailed genetic and cell-biological studies will be required, however, to determine the functions of E-Syts and compare them with those of synaptotagmins, ferlins, and MCTPs.
Unusual Targeting Mechanism of E-Syts. As assayed with myctagged transfected proteins, E-Syt1 is localized to intracellular membranes, whereas E-Syt2 and E-Syt3 are quantitatively deposited into the plasma membrane (Fig. 3) . Unexpectedly, the intracellular vesicular localization of E-Syt1 and the plasma membrane localization of E-Syt2 and E-Syt3 were independent of their TMRs, whereas the C 2 C domains of these proteins were sufficient for their localizations (Fig. 4) .
We are not aware of a previous example in which a C 2 domain directs the localization of a protein, suggesting that the mechanism described here is previously uncharacterized. This mechanism presumably involves interaction of the E-Syt2 C 2 C domain with another plasma membrane protein, similar to the interaction of the Munc13 C 2 A domain with RIM (13), as suggested by two observations. First, the E-Syt2 C 2 B/C 2 C domain, localized to the plasma membrane, is detergent-insoluble and thus not phospholipid-bound (SI Fig. 7) . Second, although the detergentinsolubility of the E-Syt2 C 2 B/C 2 C domain suggests a possible role for the cytoskeleton in its localization, drugs that disrupt either the actin or the microtubule cytoskeleton did not alter the plasma membrane localization or insolubility of the E-Syt2 C 2 B/C 2 C domain fragment (SI Fig. 7 ). These results suggest that although the E-Syt2 and E-Syt3 TMR is anchored in the plasma membrane as evidenced by the extracellularly exposed Nterminal sequence, E-Syt2 and E-Syt3 may be involved in an independent interaction with the plasma membrane via their C-terminal C 2 C domain that presumably binds to a detergentinsoluble, as yet unidentified plasma membrane component. This binding likely not only mediates the targeting of E-Syt2 and E-Syt3 to the plasma membrane but is also probably involved in their unknown functions at the plasma membrane.
Experimental Procedures
Cloning, Sequence Analyses, and Data Bank Searches. E-Syts were identified by databank searches of genomic and cDNA sequences. Their full-length human sequences were then assembled by sequencing of expressed-sequence tag clones, and submitted to GenBank (accession nos. DQ993200, DQ993201, and DQ993202).
Expression and Purification of Recombinant GST Fusion Proteins. The cDNA sequences encoding various domains of the human E-Syts were amplified by PCR, subcloned into pGEX-KG vector, and expressed and purified as recombinant GST fusion proteins essentially as described (19) . The following GST fusion proteins were produced: E-Syt1 X C 2 AB (residues 91-600), E-Syt1 C 2 A (residues 278-449), E-Syt1 C 2 E (residues 918-1105), E-Syt2 X C 2 AB (residues 147-658), E-Syt2 X C 2 A (residues 147-511), E-Syt2 X (residues 147-387), E-Syt2 C 2 A (residues 340-511), E-Syt2 C 2 AB (residues 340-658), E-Syt2 C 2 B (residues 500-658), and E-Syt2 C 2 C (residues 736-922).
Construction and Expression of Vectors Encoding Various myc-Tagged
E-Syt Fusion Proteins. The following gene constructs were subcloned into pCMV vector with an N-terminal myc-tag, and transfected into HEK293 cells for subcellular localization experiments: E-Syt1 full-length (residues 1-1105), E-Syt2 fulllength (residues 1-922), E-Syt3 full-length (residues 1-887), E-Syt1 ⌬TM (residues 92-1105), E-Syt2 ⌬TM (residues 150-922), E-Syt3 ⌬TM (residues 73-887), E-Syt2 deletion constructs (residues 1-810, 1-458, 1-240, 240-922, 458-922, and 755-922), E-Syt1 deletion construct (residues 965-1105), and E-Syt3 deletion construct (residues 748-887).
Phospholipid binding assays were carried out with purified soluble GST fusion proteins in buffer A (50 mM Hepes-NaOH, pH 6.8/0.1 M NaCl/4 mM sodium EGTA). The GST fusion C 2 domain proteins were incubated with liposomes of defined phospholipid composition in buffer A containing variable amounts of CaCl 2 or MgCl 2 to provide defined concentrations of free Ca 2ϩ and Mg 2ϩ ,respectively (calculated by using EqCal for Windows software from Biosoft, Ferguson, MO). After incubations, liposomes with bound C 2 -domain proteins were isolated by centrifugation essentially as described (31, 32) and bound proteins were precipitated, resuspended in 30 l of 2ϫ SDS sample buffer, and analyzed by SDS/PAGE and Coomassie blue staining.
Immunostaining and Confocal Imaging. HEK293 cells plated on cover slips in 12-well plates were transfected with E-Syt expression and control vectors by using FuGENE (Roche Applied Science, Indianapolis, IN). Two days after transfection, cells were washed in PBS and fixed with 3.7% formaldehyde in PBS.
After fixation, cells were blocked and nonpermeabilized or permeabilized by 3% nonfat milk with 0.1% Nonidet P-40 in PBS. Cells were then incubated with monoclonal antibodies against the myc epitope (Santa Cruz Biotechnology, Santa Cruz, CA) and FITC-conjugated Phalloidin (Molecular Probes, Eugene, OR) for 1 h, washed three times with PBS, and reacted with Alexa Fluor 488-labeled secondary antibody (Invitrogen, Carlsbad, CA) for 1 h. After three washes with PBS, cells were briefly immersed in water, and mounted with Vectashield (Vector Laboratories, Burlingame, CA). Images were acquired on a TCS2 laser-scanning confocal microscope (Leica, Bannockburn, IL) using a magnification ϫ62 oil objective.
Miscellaneous Procedures. SDS/PAGE and immunoblotting were performed by using standard procedures (22, 23) . Immunoblots were developed by enhanced chemiluminescence (Amersham Biosciences, Piscataway, NJ).
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